Protein kinase D1 is essential for the proinflammatory response induced by hypersensitivity pneumonitis-causing thermophilic actinomycetes Saccharopolyspora rectivirgula

Journal of Immunology

Volumn 184, Issue 6, 2010, Pages 3145-3156

  Kim, Young In ^a   Park, Jeoung Eun ^a   Brand, David D ^a,b   Fitzpatrick, Elizabeth A ^a   Yi, Ae Kyung ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 DIMETHYLAMINOPROPYL) 5 METHOXY 1H INDOL 3 YL] 3 (1H INDOL 3 YL)MALEIMIDE; CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; MYELOPEROXIDASE; PROTEIN KINASE D; PROTEIN KINASE D1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; AUTACOID; BACTERIAL ANTIGEN; MYD88 PROTEIN, MOUSE; PROTEIN KINASE C;

ALLERGIC PNEUMONITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENE SILENCING; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLITIS; LUNG ALVEOLUS CELL; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SACCHAROPOLYSPORA RECTIVIRGULA; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; OCCUPATIONAL LUNG DISEASE; PATHOLOGY; PHYSIOLOGY; SACCHAROPOLYSPORA;

ANIMALS; ANTIGENS, BACTERIAL; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FARMER'S LUNG; INFLAMMATION MEDIATORS; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; NEUTROPHIL INFILTRATION; NF-KAPPA B; PROTEIN KINASE C; SACCHAROPOLYSPORA;

EID: 77951895550     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903718     Document Type: Article

References (52)

1. Girard, M., Y. Lacasse, and Y. Cormier. 2009. Hypersensitivity pneumonitis. Allergy 64: 322-334.
2. Lacasse, Y., E. Israël Assayag, M. Laviolette, and Y. Cormier. 2004. [Clinical and immunopathological aspects of hypersensitivity pneumonitis]. Rev. Mal. Respir. 21: 769-781.
3. Losa García, J. E., F. M. Rodríguez, M. R. Martín de Cabo, M. J. García Salgado, J. P. Losada, L. G. Villarón, A. J. López, and J. L. Arellano. 1999. Evaluation of inflammatory cytokine secretion by human alveolar macrophages. Mediators Inflamm. 8: 43-51.
4. Nance, S. C., A. K. Yi, F. C. Re, and E. A. Fitzpatrick. 2008. MyD88 is necessary for neutrophil recruitment in hypersensitivity pneumonitis. J. Leukoc. Biol. 83: 1207-1217.
5. Shijubo, N., K. Imai, K. Shigehara, M. Hirasawa, M. Tsujisaki, Y. Hinoda, and S. Abe. 1995. Soluble intercellular adhesion molecule-1 (ICAM-1) in sera and bronchoalveolar lavage (BAL) fluids of extrinsic allergic alveolitis. Clin. Exp. Immunol. 102: 91-97.
6. Gudmundsson, G., A. Bosch, B. L. Davidson, D. J. Berg, and G. W. Hunninghake. 1998. Interleukin-10 modulates the severity of hypersensitivity pneumonitis in mice. Am. J. Respir. Cell Mol. Biol. 19: 812-818.
7. Gudmundsson, G., and G. W. Hunninghake. 1999. Respiratory epithelial cells release interleukin-8 in response to a thermophilic bacteria that causes hypersensitivity pneumonitis. Exp. Lung Res. 25: 217-228.
8. Gudmundsson, G., M. M. Monick, and G. W. Hunninghake. 1998. IL-12 modulates expression of hypersensitivity pneumonitis. J. Immunol. 161: 991-999. (Pubitemid 28323567)
9. Israël-Assayag, E., A. Dakhama, S. Lavigne, M. Laviolette, and Y. Cormier. 1999. Expression of costimulatory molecules on alveolar macrophages in hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med. 159: 1830-1834.
10. Schuyler, M., K. Gott, and A. Cherne. 2000. Mediators of hypersensitivity pneumonitis. J. Lab. Clin. Med. 136: 29-38.
11. Schuyler, M., K. Gott, and A. Cherne. 2003. Experimental hypersensitivity pneumonitis: role of MCP-1. J. Lab. Clin. Med. 142: 187-195.
12. Ismail, T., C. McSharry, and G. Boyd. 2006. Extrinsic allergic alveolitis. Respirology 11: 262-268.
13. Patel, A. M., J. H. Ryu, and C. E. Reed. 2001. Hypersensitivity pneumonitis: current concepts and future questions. J. Allergy Clin. Immunol. 108: 661-670.
14. Nance, S., R. Cross, A. K. Yi, and E. A. Fitzpatrick. 2005. IFN-γ production by innate immune cells is sufficient for development of hypersensitivity pneumonitis. Eur. J. Immunol. 35: 1928-1938.
15. Yamasaki, H., M. Ando, W. Brazer, D. M. Center, and W. W. Cruikshank. 1999. Polarized type 1 cytokine profile in bronchoalveolar lavage T cells of patients with hypersensitivity pneumonitis. J. Immunol. 163: 3516-3523. (Pubitemid 29431858)
16. Suga, M., H. Yamasaki, K. Nakagawa, H. Kohrogi, and M. Ando. 1997. Mechanisms accounting for granulomatous responses in hypersensitivity pneumonitis. Sarcoidosis Vasc. Diffuse Lung Dis. 14: 131-138.
17. Denis, M., and D. Bisson. 1995. Antigen-induced alveolitis: cytokine production in a mouse model. Inflammation 19: 157-177.
18. Reynolds, S. P., K. P. Jones, J. H. Edwards, and B. H. Davies. 1989. Immunoregulatory proteins in bronchoalveolar lavage fluid. A comparative analysis of pigeon breeders' disease, sarcoidosis and idiopathic pulmonary fibrosis. Sarcoidosis 6: 125-134.
19. Salvaggio, J. E. 1990. Recent advances in pathogenesis of allergic alveolitis. Clin. Exp. Allergy 20: 137-144.
20. Gudmundsson, G., and G. W. Hunninghake. 1997. Interferon-gamma is necessary for the expression of hypersensitivity pneumonitis. J. Clin. Invest. 99: 2386-2390.
21. Aderem, A., and R. J. Ulevitch. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406: 782-787.
22. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
23. Fernandes-Alnemri, T., J. W. Yu, P. Datta, J. Wu, and E. S. Alnemri. 2009. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458: 509-513.
24. Fritz, J. H., R. L. Ferrero, D. J. Philpott, and S. E. Girardin. 2006. Nod-like proteins in immunity, inflammation and disease. Nat. Immunol. 7: 1250-1257.
25. Hornung, V., A. Ablasser, M. Charrel-Dennis, F. Bauernfeind, G. Horvath, D. R. Caffrey, E. Latz, and K. A. Fitzgerald. 2009. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458: 514-518.
26. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5: 730-737.
27. Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5: 987-995.
28. Netea, M. G., J. W. Van der Meer, and B. J. Kullberg. 2006. Recognition of pathogenic microorganisms by Toll-like receptors. Drugs Today (Barc). 42 (Suppl A): 99-105.
29. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21: 335-376.
30. O'Neill, L. A., and A. G. Bowie. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7: 353-364.
31. Li, S., A. Strelow, E. J. Fontana, and H. Wesche. 2002. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc. Natl. Acad. Sci. USA 99: 5567-5572.
32. Suzuki, N., S. Suzuki, G. S. Duncan, D. G. Millar, T. Wada, C. Mirtsos, H. Takada, A. Wakeham, A. Itie, S. Li, et al. 2002. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416: 750-756.
33. Jeohn, G. H., C. L. Cooper, K. J. Jang, B. Liu, D. S. Lee, H. C. Kim, and J. S. Hong. 2002. Gö6976 inhibits LPS-induced microglial TNFα release by suppressing p38 MAP kinase activation. Neuroscience 114: 689-697.
34. Kobayashi, K., L. D. Hernandez, J. E. Galán, C. A. Janeway, Jr., R. Medzhitov, and R. A. Flavell. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110: 191-202. (Pubitemid 34876547)
35. Lye, E., C. Mirtsos, N. Suzuki, S. Suzuki, and W. C. Yeh. 2004. The role of interleukin 1 receptor-associated kinase-4 (IRAK-4) kinase activity in IRAK-4-mediated signaling. J. Biol. Chem. 279: 40653-40658.
36. Conze, D. B., C. J. Wu, J. A. Thomas, A. Landstrom, and J. D. Ashwell. 2008. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation. Mol. Cell. Biol. 28: 3538-3547.
37. Lamothe, B., A. Besse, A. D. Campos, W. K. Webster, H. Wu, and B. G. Darnay. 2007. Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation. J. Biol. Chem. 282: 4102-4112.
38. Takaesu, G., S. Kishida, A. Hiyama, K. Yamaguchi, H. Shibuya, K. Irie, J. Ninomiya-Tsuji, and K. Matsumoto. 2000. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol. Cell 5: 649-658.
39. Wang, C., L. Deng, M. Hong, G. R. Akkaraju, J. Inoue, and Z. J. Chen. 2001. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412: 346-351. (Pubitemid 32694385)
40. Häcker, H., R. M. Vabulas, O. Takeuchi, K. Hoshino, S. Akira, and H. Wagner. 2000. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF) 6. J. Exp. Med. 192: 595-600.
41. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745. (Pubitemid 32015992)
42. Kanayama, A., R. B. Seth, L. Sun, C. K. Ea, M. Hong, A. Shaito, Y. H. Chiu, L. Deng, and Z. J. Chen. 2004. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol. Cell 15: 535-548. (Pubitemid 39141781)
43. Yi, A. K., J. G. Yoon, and A. M. Krieg. 2003. Convergence of CpG DNA- and BCR-mediated signals at the c-Jun N-terminal kinase and NF-kappaB activation pathways: regulation by mitogen-activated protein kinases. Int. Immunol. 15: 577-591.
44. Yi, A. K., J. G. Yoon, S. J. Yeo, S. C. Hong, B. K. English, and A. M. Krieg. 2002. Role of mitogen-activated protein kinases in CpG DNA-mediated IL-10 and IL-12 production: central role of extracellular signal-regulated kinase in the negative feedback loop of the CpG DNA-mediated Th1 response. J. Immunol. 168: 4711-4720.
45. Park, J. E., Y. I. Kim, and A. K. Yi. 2009. Protein kinase D1 is essential for MyD88-dependent TLR signaling pathway. J. Immunol. 182: 6316-6327.
46. Park, J. E., Y. I. Kim, and A. K. Yi. 2008. Protein kinase D1: a new component in TLR9 signaling. J. Immunol. 181: 2044-2055.
47. Waldron, R. T., and E. Rozengurt. 2003. Protein kinase C phosphorylates protein kinase D activation loop Ser744 and Ser748 and releases autoinhibition by the pleckstrin homology domain. J. Biol. Chem. 278: 154-163.
48. Yeo, S. J., J. G. Yoon, S. C. Hong, and A. K. Yi. 2003. CpG DNA induces self and cross-hyporesponsiveness of RAW264.7 cells in response to CpG DNA and lipopolysaccharide: alterations in IL-1 receptor-associated kinase expression. J. Immunol. 170: 1052-1061.
49. Gschwendt, M., S. Dieterich, J. Rennecke, W. Kittstein, H. J. Mueller, and F. J. Johannes. 1996. Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett. 392: 77-80.
50. Ivison, S. M., N. R. Graham, C. Q. Bernales, A. Kifayet, N. Ng, L. A. Shobab, and T. S. Steiner. 2007. Protein kinase D interaction with TLR5 is required for inflammatory signaling in response to bacterial flagellin. J. Immunol. 178: 5735-5743.
51. Song, M. J., Y. Q. Wang, and G. C. Wu. 2007. Lipopolysaccharide-induced protein kinase D activation mediated by interleukin-1β and protein kinase C. Brain Res. 1145: 19-27.
52. Kato, A., and R. P. Schleimer. 2007. Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity. Curr. Opin. Immunol. 19: 711-720.